StemRIM Inc. Stock: price and insider trades · Japan

StemRIM Inc. is a Health Care company. Its directors and officers file their transactions with EDINET (Japan FSA). Over the twelve months to 18 October 2026, 3 filings were filed, from 1 insider.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Insider buying of StemRIM Inc. has been absent for the past year. The median gap between a trade and its publication by EDINET (Japan FSA) is 7 days. That lag is the time during which only the insider knows about the trade.

Compared with its exchange (3,419 companies, median 3 filings), a count of 3 filings is typical.

Elsewhere in the same sector, our signals recently picked up insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. These figures are compiled from regulatory filings published by EDINET (Japan FSA). They describe what insiders did and are not a recommendation.